Holen Sie sich die Stockscreener-App
20.86
1.24%
-0.18
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 0.925 |
Operating Expenses
|
0.63%
26.08
|
25.92 | 21.51 | 22.18 | 21.06 |
| Operating Income/Loss |
0.63%
-26.08
|
-25.92 | -21.51 | -22.18 | -20.13 |
| Income/Loss From Continuing Operations Before Tax |
2.79%
-22.02
|
-22.65 | -76.07 | -20.22 | -18.49 |
| Income/Loss From Continuing Operations After Tax |
2.79%
-22.02
|
-22.65 | -19.51 | -20.22 | -18.49 |
|
Net Income/Loss
|
2.79%
-22.02
|
-22.65 | -19.51 | -20.22 | -18.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.28%
21.06
|
21.00 | 0.6341 | 16.95 | 16.94 |
| Diluted Average Shares |
0.28%
21.06
|
21.00 | 0.6341 | 16.95 | 16.94 |
| Basic Earnings Per Share |
2.78%
-1.05
|
-1.08 | -0.99 | -1.19 | -1.09 |
| Diluted Earnings Per Share |
2.78%
-1.05
|
-1.08 | -0.99 | -1.19 | -1.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.79%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):